Emergent BioSolutions Inc. (EBS) Stock

Emergent BioSolutions Inc. (EBS) is a Healthcare stock trading at $7.98 (as of 2026-06-18), with a market capitalization of $470.56M and a trailing P/E of -43.8. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

Emergent BioSolutions Inc. is a life sciences company focused on preparedness and response products for public health threats, including chemical, biological, radiological, nuclear, and explosive events, as well as emerging infectious diseases and related emergency care needs in the United States. Its portfolio includes vaccines, antitoxins and immunoglobulin therapies, antibody treatments, decontamination products, and some emergency treatments and travel-related vaccines.

Valuation — source: SEC EDGAR (first-party)
Price$7.98
Market Cap$470.56M
P/E Ratio-43.8
EV / EBITDA5.4
Price / Book0.82
Price / Sales0.63
DCF Value (model)$63.79
DCF Upside vs Price699.4%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$742.90M
Net Margin7.1%
Return on Equity-1.6%
Debt / Equity1.10
Current Ratio4.29
Revenue Growth (YoY)-28.8%
EPS Growth (YoY)-127.2%
FCF Growth (YoY)338.0%
Financial Health — source: SEC EDGAR
Altman Z-Score1.44 (distress)
Piotroski F-Score8/9 (strong)
Valuation vs Sector & Industry
Stock P/E-43.8
Sector P/E (Healthcare)20.9
Industry P/E (Pharmaceutical Products)17.0
vs Sector-309.6%
vs Industry-357.4%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderBlackRock Fund Advisors ($87.47M)
Institutional Holders Tracked10
Company
SectorHealthcare
IndustryPharmaceutical Products
CEOJoseph C. Papa Jr.
Employees900
CountryUS
IPO Date2006-11-15

Related Companies (Business model: Biotech (Clinical / Commercial-Stage); 8 closest by market cap; US-domiciled)

  • Invivyd, Inc. (IVVD)
  • Organogenesis Holdings Inc. (ORGO)
  • Lyell Immunopharma, Inc. (LYEL)
  • MeiraGTx Holdings plc (MGTX)
  • Gyre Therapeutics, Inc. (GYRE)
  • Prime Medicine, Inc. (PRME)
  • Cullinan Therapeutics, Inc. (CGEM)
  • SELLAS Life Sciences Group, Inc. (SLS)
EBS earnings history · EBS institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.